AEON Biopharma, Inc. (AEON) — Financial Flexibility Index
AEON Biopharma, Inc. (AEON) has a Financial Flexibility Index of -0.09x as of September 2025. Free cash flow of $-2.60 Million (operating CF $-2.60 Million minus capex $0.00) represents 0% of total liabilities ($28.61 Million). Check AEON asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
AEON Biopharma, Inc. Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for AEON Biopharma, Inc. across 6 annual periods. See working capital to net assets of AEON Biopharma, Inc. to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for AEON Biopharma, Inc. (2019–2024)
Year-by-year free cash flow to debt coverage for AEON Biopharma, Inc.. For the full company profile including market capitalisation, see AEON market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.64x | $-20.29 Million | $-20.29 Million | $31.71 Million | ▼ -113.9% |
| 2023 | -0.30x | $-47.83 Million | $-47.83 Million | $159.89 Million | ▼ -138.4% |
| 2022 | -0.13x | $-35.28 Million | $-35.58 Million | $281.19 Million | ▼ -2.2% |
| 2021 | -0.12x | $-28.26 Million | $-28.43 Million | $230.26 Million | ▼ -196.5% |
| 2020 | -0.04x | $-9.29 Million | $-9.46 Million | $224.45 Million | ▲ +82.7% |
| 2019 | -0.24x | $-43.03 Million | $-44.73 Million | $180.22 Million | — |